Tropic Biosciences

Evolving Agriculture. Sustaining People & Planet.

Norwich, United Kingdom · Founded 2016 · $143.5M raised

Headquarters
Norwich
Employees
51–200
Founded
2016
Business Model
B2B
Website
tropic.bio
Total Funding
$143.5M
Last Round
$105.0M Series CMar 2026
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Tropic (formerly Tropic Biosciences) is a UK-based agricultural biotechnology company that uses cutting-edge gene editing techniques to develop high-performance varieties of tropical commodity crops. Their proprietary GEiGS® (Gene Editing induced Gene Silencing) platform combines the precision of gene editing with the versatility of gene silencing (RNAi). The company focuses on improving crop resistance to critical diseases, reducing pesticide reliance, and improving supply chain sustainability — primarily for banana, coffee, and rice growers across the tropics.

Summary

Tropic Biosciences is a Healthcare company based in Norwich, United Kingdom, founded in 2016. It has raised $143.5M in total across 3 rounds, most recently a $105.0M Series C round in Mar 2026. Investors include Five Seasons Ventures, Corteva and Forbion Capital Partners.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CGrowth RoundMar 2026
$105.0M

Sign up to see all 3 events

Funding: Series A through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Tropic Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/tropic-biosciences"><img src="https://indexed.vc/api/badge/company/tropic-biosciences" alt="Tropic Biosciences on Indexed.vc" width="260" height="76" /></a>